MacroGenics Inc. (NASDAQ:MGNX)’s traded shares stood at 0.87 million during the latest session, with the company’s beta value hitting 1.96. At the last check today, the stock’s price was $7.25, to imply an increase of 14.35% or $0.91 in intraday trading. The MGNX share’s 52-week high remains $10.20, putting it -40.69% down since that peak but still an impressive 70.62% since price per share fell to its 52-week low of $2.13. The company has a valuation of $452.04M, with an average of 0.69 million shares in intraday trading volume over the past 10 days and average of 669.26K shares over the past 3 months.
Analysts have given a consensus recommendation of an Overweight for MacroGenics Inc. (MGNX), translating to a mean rating of 1.90. Of 10 analyst(s) looking at the stock, 0 analyst(s) give MGNX a Sell rating. 1 of those analysts rate the stock as Overweight while 2 advise Hold as 7 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at $0.25.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
MacroGenics Inc. (NASDAQ:MGNX) trade information
After registering a 14.35% upside in the latest session, MacroGenics Inc. (MGNX) has traded red over the past five days. The stock hit a weekly high of 7.49 this Wednesday, 03/15/23, jumping 14.35% in its intraday price action. The 5-day price performance for the stock is 17.50%, and 38.36% over 30 days. With these gigs, the year-to-date price performance is 8.05%. Short interest in MacroGenics Inc. (NASDAQ:MGNX) saw shorts transact 4.6 million shares and set a 8.49 days time to cover.
Analysts on Wall Street suggest a consensus price target of $10.63, implying an increase of 31.8% to the stock’s recent value. The extremes give us $6.00 and $17.00 for target low and target high price respectively. As such, MGNX has been trading -134.48% off suggested target high and 17.24% from its likely low.
MacroGenics Inc. (MGNX) estimates and forecasts
Looking at statistics comparing MacroGenics Inc. share performance against respective industry, we note that the company has outperformed competitors. MacroGenics Inc. (MGNX) shares are 110.14% up over the last 6 months, with its year-to-date growth rate higher than industry average at 53.85% against 9.40%. Revenue is forecast to grow 126.30% this quarter before jumping 64.80% for the next one. The rating firms project that company’s revenue will grow 99.10% compared to the previous financial year.
Revenue forecast for the current quarter as set by 9 analysts is $70.12 million. Meanwhile, for the quarter ending Mar 2023, a total of 5 analyst(s) estimate revenue growth to $38.45 million.Earnings reports from the last fiscal year show that sales brought in $14.15 million and $11.1 million respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 395.70% before jumping 246.40% in the following quarter.
MacroGenics Inc. has its next earnings report out between May 01 and May 05. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. MacroGenics Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
MacroGenics Inc. (NASDAQ:MGNX)’s Major holders
MacroGenics Inc. insiders hold 2.60% of total outstanding shares, with institutional holders owning 95.66% of the shares at 98.21% float percentage. In total, 95.66% institutions holds shares in the company, led by Bellevue Group AG. As of Sep 29, 2022, the company held over 7.33 million shares (or 11.92% of shares), all amounting to roughly $25.35 million.
The next major institution holding the largest number of shares is Armistice Capital, LLC with 6.13 million shares, or about 9.97% of shares outstanding. As of the market price on Sep 29, 2022, these shares were worth $21.2 million.
We also have Vanguard Total Stock Market Index Fund and Wasatch Ultra Growth Fund as the top two Mutual Funds with the largest holdings of the MacroGenics Inc. (MGNX) shares. Going by data provided on Sep 29, 2022, Vanguard Total Stock Market Index Fund holds roughly 1.88 million shares. This is just over 3.05% of the total shares, with a market valuation of $6.49 million. Data from the same date shows that the other fund manager holds a little less at 1.83 million, or 2.97% of the shares, all valued at about 6.32 million.